Optinose Announces Reporting Date for Second Quarter 2020 Financial Results
Optinose (NASDAQ: OPTN) announced that it will report its second quarter 2020 financial results and corporate updates on August 4, 2020, before market open. The leadership team will host a conference call at 8:00 a.m. ET on the same day to discuss these results, including the launch of XHANCE®. Participants can join the call via U.S. or international numbers, with a replay available until August 11, 2020. The event will also be accessible through a webcast on Optinose's website.
- Launch of XHANCE® expected to contribute positively to revenue growth.
- No specific financial metrics provided for the second quarter 2020.
YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the second quarter 2020 and corporate updates, before market open on Tuesday, August 4, 2020.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates, including its launch of XHANCE®. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, August 4, 2020.
To participate on the conference call, please dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until Tuesday, August 11, 2020 by dialing (855) 859-2056 from the U.S. or +1 (404) 537-3406 from outside the U.S. and entering conference ID #2298719. A simultaneous webcast of the call and presentation can be accessed by visiting the Investors section of Optinose’s website at www.optinose.com. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
When will Optinose report its second quarter 2020 financial results?
What time is Optinose's conference call for second quarter results?
How can I participate in the Optinose conference call?
Is there a webcast available for the Optinose conference call?
What is being discussed during the Optinose conference call?
